drugset
drugset / Trial / NCT07475286

Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis

NCT07475286 ↗

Phase 2 Recruiting 22 enrolled Mohammad Haroon Asif Choudry Dr. Samer AlMasri, MD · collab
NaSingle-groupOpen-labelTreatment

Summary

This trial will administer laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis from gastric cancer (GPC) who are receiving standard of care systemic chemotherapy.

Timeline

Start
2026-06-12
Primary completion
2030-06-30
Completion
2034-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 100 mg/m2 Other
Subject Mitomycin C Other / unclassified 30 mg Other

Indications

peritoneal carcinomatosis